Research, editing : Gan Yung Chyan, KUCINTA SETIA
News on covi traceability, CCP, Taiwan, disease control, U.S., airport management
News (1) to (2) / Reporter : Natalie Winters, The National Pulse
News (1)
Unearthed Wuhan lab document shows Shi Zhengli isolating coronavirus strains for "direct human infection"
Shi Zhengli – the Wuhan Institute of Virology’s premier bat coronavirus researcher – celebrated her isolation of a coronavirus strain that could cause “direct human infection” in an annual lab report unearthed by The National Pulse.
The admission follows mounting evidence that COVID-19 traces
its origins to the Wuhan-based lab and can be linked to risky “gain-of-function”
research funded by Anthony Fauci. A “longtime collaborator” of several Fauci-funded
researchers, Shi, also known as “Bat Lady,” has listed grants from the National
Institute of Allergy and Infectious Diseases (NIAID) Director on her resume.
Shi’s biography and research accomplishments, which appear in the
lab’s 2013 annual report exclusively unearthed by The National Pulse, augment
her ties to the scientific research carried out at the Wuhan Institute of
Virology that likely led to COVID-19.
The subheading “Research Interests” included in Shi’s profile
outlines the focus of her work in her capacity as the Director of the lab’s
Center for Emerging Infectious Diseases. “This group focuses on emerging viral
pathogens and their infection mechanisms,” the synopsis begins before providing
examples of her work on the “interspecies infection mechanism of zoonotic
virus” such as SARS-like coronaviruses:
“Viral isolation and characterization,
diagnostic method development and genomic studies molecular epidemiology and
interspecies infection mechanism or zoonotic virus (SARS-like-CoV, Nipah virus,
Hantavirus, etc); viral metagenomics in particular niche samples (animals and
environments).”
The summary also references how coronaviruses “achieved cross-species infection by mutation of key sites of the spike protein,” which is the mechanism that allows COVID-19 to enter human cells.
Ref: https://thenationalpulse.com/exclusive/wuhan-report-boasted-of-human-infecting-covid/
News (2)
The unearthed affiliation follows the National Institutes of Health (NIH) admitting the New York-based nonprofit carried out gain of function research with the Chinese military-linked Wuhan lab and failed to report its findings to the federal agency. Gain of function research, which counts support from EcoHealth Alliance President Peter Daszak, increases the virulence, lethality, and transmissibility of viruses including bat coronaviruses. Daszak has previously described the viruses he and his Chinese colleagues were manipulating as “killers” in video unearthed by The National Pulse.
In addition to receiving sizable grants from Fauci’s National Institute of Allergy and Infectious Diseases (NIAID) and hosting Fauci repeatedly as a speaker at its events, EcoHealth Alliance also appears to retain close relationships to additional federal agencies such as the Centers for Disease Control and Prevention (CDC) through its research partnerships.
Three officials from the CDC are listed as active “partners” of EcoHealth Alliance along with one NIH official on the group’s website.
Since September 2012, two years before Fauci’s NIH agency funded EcoHealth Alliance’s bat coronavirus research with the Wuhan lab, Dr. Rima Khabbaz, the Director of the CDC’s National Center for Emerging and Zoonotic Infectious Diseases has been listed as on the group’s official partners.
Since April 2015, Dr. Heinz Feldmann, a Senior Investigator at the NIH, has also been a partner of EcoHealth Alliance. Feldman’s NIH biography describes him as a “laboratory expert on high containment viruses (BSL-4)” – the same biosafety level of the Wuhan Institue of Virology facility working on bat coronaviruses. Capt. Jason Thomas, the Biosurveillance Coordinator at the CDC, along with Dr. Stuart Nichol, Chief of the Molecular Biology Section of the Special Pathogens Branch at the CDC, have also been listed as EcoHealth Alliance partners since April 2015.
All aforementioned federal officials are still listed as EcoHealth Alliance partners, classified as “Science and Policy Advisors,” at the time of publication. Among the group’s other advisors is the Deputy Director for Surveillance and Epidemiology at the Bill & Melinda Gates Foundation and World Health Organization (WHO) officials.
Ref: https://thenationalpulse.com/news/cdc-nih-officials-listed-as-ecohealth-partners/
See also: https://thenationalpulse.com/exclusive/fauci-funded-researchers-lectured-at-wuhan-lab/
News (3) to (6) / Reporters : Ning Haizhong and Luo Ya / https://www.epochtimes.com/gb/21/11/8/n13362729.htm
News (3)
The Sixth Plenary Session of the 19th Central Committee of the Communist Party of China was held in Beijing on 8 November 2021. The four-day meeting will review and approve the third session of the Communist Party of China. A "historical resolution". Xi Jinping's statement that the CCP "does not deny each other for 30 years" once again caused interpretation. In addition, experts also analyzed the personnel layout of the Sixth Plenary Session of the Central Committee of the Communist Party of China or the 20th National Congress of the Communist Party of China.
On 9 November, the Sixth Plenary Session of the Communist Party of China entered the second day, the party media Xinhua News Agency issued a 12,000-word comment, but "Jiang Zemin" and "Three Represents" were not seen at all. The words may imply a new trend of "power struggle within the party."
News (10)
News (17)
Taiwan bought the anti-covid oral drug! Chen Shizhong revealed that he has signed a contract with Merck
Reporter : Qiu Zhirou / https://news.ltn.com.tw/news/life/breakingnews/3732053
Image : The American pharmaceutical company Merck has developed the world's first oral drug "Molnupiravir" to fight covid. (AFP)
The American pharmaceutical company Merck has developed the world's first anti-covid oral drug "Molnupiravir". Good news has finally been released regarding the procurement progress of my country, the central epidemic Chen Shizhong, the commander of the command center, revealed in the Legislative Yuan on 10 November 2021 that "the contract has been completed."
Molnupiravir is an oral anti-covid drug, which is mainly used to treat patients with mild to moderate COVID-19 diagnosed early. The third phase of the drug was conducted internationally. Taiwan, including National Taiwan University Hospital and Taoyuan Hospital of the Ministry of Health and Welfare, have accepted cases. According to Merck’s clinical trial data, Molnupiravir can effectively reduce the risk of hospitalization or death of confirmed patients by 50%. The U.S. Food and Drug Administration (FDA) is currently reviewing the emergency use authorization (EUA) of the drug and is expected to make a decision before the end of the year. .
Chen Shizhong attended the Health and Environment Committee of the Legislative Yuan this morning. In response to a question from the People’s Party legislator Cai Biru, he said that the purchase progress of Merck’s oral drug has been signed recently. In addition, Chen Shizhong also said that Pfizer’s anti-covid drug "PF-07321332" has also been requested by a pharmaceutical company. Experts explain that the research data seems to be good at the moment, and Taiwan will consider buying it.
Chen Shizhong has stated many times before that he is ready to purchase and continues to negotiate with pharmaceutical companies. Today, the Legislative Yuan revealed good news. Chen Shizhong also further stated that the purchase amount will be more than 10,000 copies, "but the amount is not even clear to me." , Because international prices are usually not asked and cannot be bargained, but the current contract is better than before, and there is no strict restriction and it is impossible to talk about the purchase time.
Chen Shizhong also said that this Friday will also review Pfizer's oral covid drug with experts. At present, they "look good" and will buy them if the experts approve them. As for the old drug "Ivermectin (ivermectin)," Chen Shizhong also said that there are a lot of discussions on the pros and cons of the international part, and the command center has also considered it but domestic experts currently consider it invalid.
News (18) to (20) / Reporter : Zhang Ting / https://www.epochtimes.com/gb/21/11/9/n13365153.htm
News (18)
Demystifying the role and purpose of the Chinese Communist military in vaccine diplomacy
The Chinese Communist Party's vaccine diplomacy has once again attracted the attention of foreign media recently. The Wall Street Journal disclosed on 8 November how the CCP used the military to help it expand its overseas interests. Bloomberg reported on November 3 that the CCP used the new crown vaccine to open the way and is vigorously promoting other Chinese vaccines overseas to compete with foreign companies such as Pfizer.
The Washington Post stated that in 2021, the news that the Chinese Communist government provided personal protective equipment to a large number of developing countries has aroused widespread concern but few people have noticed the role of the Chinese Communist military in it. An analysis by the International Institute for Strategic Studies shows that by the beginning of 2021, the Chinese Communist military has provided medical supplies to the military of 56 countries and a UN peacekeeping force.
Since the beginning of this year, the Chinese Communist Army has rapidly expanded its donation of covi vaccine to the armed forces of many countries on 4 continents, including Zimbabwe, the Philippines, Ethiopia and other countries.
According to data from the Ministry of National Defense of the Communist Party of China, as of September, more than 30 batches of vaccines have been delivered to more than 20 countries.
The Washington Post stated that the CCP's military is playing an increasing role in China's vaccine diplomacy. Defense analysts and international relations scholars say that although military donations to the military are only a small part of the approximately 1.4 billion doses of vaccines sold and donated by China abroad, they are meant to help the CCP achieve the strategy necessary to compete with the United States. Adjusted for the target. Many recipient countries, such as Zimbabwe and Ethiopia, are important participants in the CCP’s “One Belt, One Road” infrastructure initiative.
News (19)
Experts analyze the purpose of military involvement in vaccine activities
The Washington Post quoted a number of scholars to analyze and point out that the CCP’s actions will help strengthen the CCP’s relations with African and Southeast Asian countries, which are important sources for the CCP to obtain natural resources or regional influence.
The Chinese Communist military’s new crown diplomacy turned to vaccines in February, first to Pakistan and Cambodia, and then to other parts of Asia. The following month, the vaccine was sent to the armies of several African countries, initially Sudan and Sierra Leone. In May, news broke that Sierra Leone signed a $55 million agreement with the Chinese Communist government to develop 250 acres of beaches and rainforest into an industrial fishing port. In August of this year, the scope of vaccines sent by the Chinese Communist military was expanded to Latin America.
In Sudan, the CCP provided 250,000 doses of vaccine to local military departments operating in the border area of South Sudan in March. The area is rich in oil resources. The CCP has a peacekeeping force stationed there and is the largest buyer of crude oil in the area. .
Helena Legarda, a researcher for China’s national defense policy at the Mercator Institute of China, said that this is completely unique to the CCP and China, because no other armed forces directly donate such large-scale vaccines to the military of other countries.
"In terms of soft power, there is nothing better than health care and education," Legada said. "In many countries, the military is a powerful and influential political force, so building a relationship with them is never bad thing."
The Ministry of National Defense of the Chinese Communist Party denies that these military actions are attached to any political conditions, and it also denies that these actions are for the pursuit of geopolitical goals.
U.S. Secretary of State Antony Blinken condemned the CCP’s “vaccine diplomacy” in March this year. He emphasized that the CCP’s vaccine diplomacy has "conditions attached."
"We should not tie the distribution or acquisition of vaccines to politics or geopolitics." Brinken said that this policy has "conditions attached, certain requirements, perhaps stronger requirements for other countries, (these countries) Before you can receive the vaccine".
The CCP’s donation of vaccines to other militaries does not always leave a positive impression on people in the recipient country. "Hua Ri" quoted Richard Heydarian, an Asian geopolitical scholar based in Manila, as saying that in the Philippines, many people believe that these donations are marketing for future commercial vaccine sales.
News (20)
China shares the covi vaccine to open the way to vigorously promote other Chinese vaccines
The covid pandemic gives the CCP an opportunity to use covi vaccine diplomacy to expand its influence in the receiving country. Bloomberg reported on 3 November 2021 that the CCP is now using this new influence to compete with Pfizer and Merck. The company (Merck & Co) competes and actively promotes vaccines against Japanese encephalitis and pneumonia overseas.
This will also help the Xi Jinping government to exert more soft power on a global scale.
China National Pharmaceutical Group is a partner of a large factory near Belgrade, the capital of Serbia. The Serbian government said that the plant "will be able to produce vaccines against other diseases...not only for Serbia but also for export." In Morocco, Yunnan Watson Biotechnology Co., Ltd. is selling a vaccine to prevent childhood pneumonia. On the basis of large exports of the new crown vaccine, other Chinese companies are selling vaccines to prevent various diseases such as influenza and hepatitis to countries such as Indonesia and Egypt.
Thomas Bollyky, Director of the Global Health Program of the American Association for Foreign Relations, said, "China was not a major vaccine exporter in the past, so this transition between pandemics is one of the ways this pandemic has changed the world. It enables China to become a participant in the global vaccine field in an unprecedented way, and I think this situation will continue."
Yunnan Watson Biological Company introduced Pfizer's Prevnar 13 pneumococcal vaccine in China in 2020, and the price is 15% lower than Pfizer vaccine, making Pfizer lose more than 40% of the vaccine market in China. Watson now expects that the company's pneumococcal vaccine will achieve similar success in developing countries.
Merck's human papillomavirus vaccine also faces threats and challenges from Chinese companies.
Sinovac, the leader of China's new crown vaccine, is also developing a series of vaccines, including vaccines to prevent chickenpox and polio. Sinopharm has sold Japanese encephalitis vaccines in India and Southeast Asian countries.
Boliki said that China is likely to make progress mainly in low-income countries, which means that Chinese pharmaceutical companies will mainly compete with low-cost Indian suppliers in developing countries. However, Bloomberg pointed out that in view of the low effectiveness of China's new crown vaccine in clinical trials and the large number of new cases after large-scale vaccination in many countries, people have always questioned the ability of CCP China's vaccine to prevent infection. Some countries that rely on Chinese vaccines, including Thailand and Brazil, are now turning to more effective mRNA vaccines developed by Western companies.
Chinese drugmakers and government health departments have hardly released details on the safety of domestic vaccines. Anna Durbin, a professor of international health at the Bloomberg School of Public Health at Johns Hopkins University, said: “One of the concerns of many people is the lack of transparency in the manufacture, safety and efficacy of vaccines (in CCP China).”
News (21)
Sydney airport to be sold
No comments:
Post a Comment